189 related articles for article (PubMed ID: 11240955)
1. Skin concentrations of H1-receptor antagonists.
Simons FE; Silver NA; Gu X; Simons KJ
J Allergy Clin Immunol; 2001 Mar; 107(3):526-30. PubMed ID: 11240955
[TBL] [Abstract][Full Text] [Related]
2. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
[TBL] [Abstract][Full Text] [Related]
3. Peripheral H1-blockade effect of fexofenadine.
Simons FE; Simons KJ
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Jones DH; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast.
Simons FE; Johnston L; Gu X; Simons KJ
Ann Allergy Asthma Immunol; 2001 Jan; 86(1):44-50. PubMed ID: 11206237
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of H1-antihistamines in the skin.
Simons FE; Silver NA; Gu X; Simons KJ
J Allergy Clin Immunol; 2002 Nov; 110(5):777-83. PubMed ID: 12417888
[TBL] [Abstract][Full Text] [Related]
7. Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).
Mansfield L; Mendoza C; Flores J; Meeves SG
Ann Allergy Asthma Immunol; 2003 May; 90(5):554-9. PubMed ID: 12775138
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the central nervous system effects produced by six H1-receptor antagonists.
Simons FE; Fraser TG; Reggin JD; Simons KJ
Clin Exp Allergy; 1996 Sep; 26(9):1092-7. PubMed ID: 8889266
[TBL] [Abstract][Full Text] [Related]
9. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists.
Witek TJ; Canestrari DA; Miller RD; Yang JY; Riker DK
Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974
[TBL] [Abstract][Full Text] [Related]
10. H1-antihistaminic activity of cetirizine and fexofenadine in allergic children.
Simons FE; J Semus M; Goritz SS; Simons KJ
Pediatr Allergy Immunol; 2003 Jun; 14(3):207-11. PubMed ID: 12787300
[TBL] [Abstract][Full Text] [Related]
11. The effects of single-dose fexofenadine, diphenhydramine, and placebo on cognitive performance in flight personnel.
Bower EA; Moore JL; Moss M; Selby KA; Austin M; Meeves S
Aviat Space Environ Med; 2003 Feb; 74(2):145-52. PubMed ID: 12602446
[TBL] [Abstract][Full Text] [Related]
12. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
14. [Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction].
Grzelewska-Rzymowska I; Kroczyńska-Bednarek J; Pietrzkowicz M
Pol Merkur Lekarski; 2003 Jan; 14(79):43-6. PubMed ID: 12712828
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Carey W; Warrington S; Boyce M; Luria X
Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
17. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
19. Fexofenadine, an H1-receptor antagonist, partially but rapidly inhibits the itch of contact dermatitis induced by diphenylcyclopropenone in patients with alopecia areata.
Katagiri K; Arakawa S; Hatano Y; Fujiwara S
J Dermatol; 2006 Feb; 33(2):75-9. PubMed ID: 16556272
[TBL] [Abstract][Full Text] [Related]
20. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
